Citations

Clear

6273 citation(s) found for "To, Andrew".

Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers
Benowitz, Neal L. , West, Robert , Tonstad, Serena , McRae, Thomas, Lawrence, David , Aubin, Lisa St, Anthenelli, Robert M. , Hays, J. Taylor , Pipe, Andrew

Mayo Clinic

JAMA Internal Medicine | April 9, 2018 | Volume: 178 | Issue: 5 | Pages: 622

10.1001/jamainternmed.2018.0397 | PMID 29630702 Get It

Summative Report on Time Out of Play for Major and Minor League Baseball: An Analysis of 49,955 Injuries From 2011 Through 2016
List, Jelle P. van der , Conte, Stan, Conway, Justin , Altchek, David W. , Coleman, Struan H. , Pearle, Andrew D. , Camp, Christopher L. , Dines, Joshua S.

Mayo Clinic

The American Journal of Sports Medicine | April 9, 2018 | Volume: 46 | Issue: 7 | Pages: 1727-1732

10.1177/0363546518765158 | PMID 29629813 Get It

Background: Recent epidemiologic reports have demonstrated rising injury rates in Major League Baseball (MLB) and Minor League Baseball (MiLB). Although several studies have recently been published on specific injuries, the majority of injuries have not yet been formally studied. Purpose: The purpose of this study is to (1) generate a summative analysis of all injuries that occur in MLB and MiLB, (2) identify the 50 most common injuries, and (3) generate focused reports and fact sheets on the characteristics of each of those diagnoses. Study Design: Case series; Level of evidence, 4. Methods: The MLB Health and Injury Tracking System was used to identify injuries occurring in MLB and MiLB players from 2011 to 2016. Injuries were defined as those that occurred during normal baseball activity and resulted in at least 1 day out of play. A multitude of player and injury characteristics were analyzed, and detailed reports of the 50 most commonly occurring injuries were generated. Results: A total of 49,955 injuries occurred during the study period; 45,123 were non–season ending, and they resulted in 722,176 days out of play. The mean (median) days missed per injury was 16 (6) days. Overall, 39.1% of all injuries occurred in pitchers. The upper extremity was involved in 39% of injuries, while 35% occurred in the hip/groin/lower extremity. Surgery was required in 6.5% of cases, and 9.7% of injuries were season ending. Hamstring strains were the most common injury (n = 3337), followed by rotator cuff strain/tear (n = 1874), paralumbar muscle strain (n = 1313), biceps tendinitis (n = 1264), oblique strain (n = 1249), and elbow ulnar collateral ligament injury (n = 1191). The diagnoses that were most likely to end a player’s season were elbow ulnar collateral ligament injury (60% season ending) and superior labrum anterior and posterior tear (50.9% season ending). Conclusion: Contrary to prior reports relying on disabled list data, the annual number of injuries in professional baseball remained steady from 2011 to 2016. Similar trends were noted for the annual number of days missed and mean days missed per injury. Although the mean days missed per injury was high (16), the median was much lower at 6 days.
Prostate cancer specific mortality and overall survival outcomes for salvage radiation therapy after radical prostatectomy.
Michalski, Jeff M. , Pisansky, Thomas M. , Pollack, Alan , Zietman, Anthony L., Stephans, Kevin L. , Gao, Tianming, Stephenson, Andrew J. , Tendulkar, Rahul D. , Agrawal, Shree , Efstathiou, Jason A. , Koontz, Bridget F. , Liauw, Stanley L. , Abramowitz, Matthew C. , Anscher, Mitchell S. , Moghanaki, Drew M. , Den, Robert B. , Lee, W. Robert , Hearn, Jason W.D. , Spratt, Daniel E. , Kattan, Michael W.

Mayo Clinic

Journal of Clinical Oncology | April 9, 2018 | Volume: 2017 | Issue: 1_suppl | Pages: 9-9

10.1200/jco.2017.35.6_suppl.9.2017.1.test Get It

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Marrero, Jorge A. , Kulik, Laura , Zhu, Andrew X. , Roberts, Lewis R. , Roberts, Lewis R , Sirlin, Claude B. , Finn, Richard S. , Abecassis, Michael M. , Heimbach, Julie K.

Mayo Clinic

Hepatology | April 6, 2018 | Volume: 68 | Issue: 2 | Pages: 723-750

10.1002/hep.29913 | PMID 29624699 Get It

Comparison of Respiratory Pathogen Detection in Upper versus Lower Respiratory Tract Samples Using the BioFire FilmArray Respiratory Panel in the Immunocompromised Host
Azadeh, Natalya , Sakata, Kenneth K. , Saeed, A.I. , Mullon, John J., Grys, Thomas E. , Binnicker, Matthew J. , Saeed, Ali, Limper, Andrew H. , Grys, Thomas E

Mayo Clinic

Canadian Respiratory Journal | April 5, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-6

10.1155/2018/2685723 | PMID 29849830 Get It

Background. The FilmArray Respiratory Panel (FARP) (BioFire Diagnostics, Inc.) is a multiplex, polymerase chain reaction (PCR) technique that can detect 17 respiratory viruses and 3 bacterial targets in a single reaction. Immunocompromised hosts (ICH) with respiratory illnesses often undergo bronchoscopy with bronchoalveolar lavage (BAL). This prospective study aimed to evaluate the yield and concordance of NP and BAL FARP testing when performed on the same patient concurrently. Methods. From February to December 2016, 125 patients (100 ICH and 25 non-ICH) were enrolled. NP swabs and BAL samples were sent for FARP testing. Results. The yield of the BAL FARP among ICH and non-ICH was 24% (24/100) and 8% (2/25), respectively. The yield of positive NP swabs in ICH was 27% (27/100) versus 4% (1/25) in non-ICH. The majority of patients (89%; 111/125) had concordant results between NP and BAL specimens. Of the 24 ICH patients who had a positive BAL FARP, the majority (79%) had the same pathogen detected from the NP swab. Conclusion. The FARP may be useful in the ICH. Given the high concordance, in patients whom a pathogen is identified on the NP FARP, a FARP performed on BAL will likely yield the same result. However, if the NP FARP is negative, performing the test on a BAL sample may have an incremental yield.
Comparison of Autograft and Allograft with Surface Modification for Flexor Tendon Reconstruction
Wei, Zhuang, Reisdorf, Ramona L., Thoreson, Andrew R. , Moran, Steven L. , An, Kai‐Nan , Amadio, Peter C. , Zhao, Chunfeng , Wei, Zhuang, Jay, Gregory D.

Mayo Clinic

Journal of Bone and Joint Surgery | April 4, 2018 | Volume: 100 | Issue: 7 | Pages: e42

10.2106/jbjs.17.00925 | PMID 29613931 Get It

Background: Flexor tendon injury is common, and tendon reconstruction is indicated clinically if the primary repair fails or cannot be performed immediately after tendon injury. The purpose of the current study was to compare clinically standard extrasynovial autologous graft (EAG) tendon and intrasynovial allogeneic graft (IAG) that had both undergone biolubricant surface modification in a canine in vivo model. Methods: Twenty-four flexor digitorum profundus (FDP) tendons from the second and fifth digits of 12 dogs were used for this study. In the first phase, a model of failed FDP tendon repair was created. After 6 weeks, the ruptured FDP tendons with a scarred digit were reconstructed with the use of either EAG or IAG tendons treated with carbodiimide-derivatized hyaluronic acid and lubricin. At 12 weeks after tendon reconstruction, the digits were harvested for functional, biomechanical, and histologic evaluations. Results: The tendon failure model was a clinically relevant and reproducible model for tendon reconstruction. The IAG group demonstrated improved digit function with decreased adhesion formation, lower digit work of flexion, and improved graft gliding ability compared with the EAG group. However, the IAG group had decreased healing at the distal tendon-bone junction. Our histologic findings verified the biomechanical evaluations and, further, showed that cellular repopulation of allograft at 12 weeks after reconstruction is still challenging. Conclusions: FDP tendon reconstruction using IAG with surface modification has some beneficial effects for reducing adhesions but demonstrated inferior healing at the distal tendon-bone junction compared with EAG. These mixed results indicate that vitalization and turnover acceleration are crucial to reducing failure of reconstruction with allograft. Clinical Relevance: Flexor tendon reconstruction is a common surgical procedure. However, postoperative adhesion formation may lead to unsatisfactory clinical outcomes. In this study, we developed a potential flexor tendon allograft using chemical and tissue-engineering approaches. This technology could improve function following tendon reconstruction.
PositivePneumocystis jiroveciiSputum PCR Results with Negative Bronchoscopic PCR Results in Suspected Pneumocystis Pneumonia
Pennington, Kelly M. , Wilson, John , Escalante, Patricio , Escalante, Patricio , Limper, Andrew H.

Mayo Clinic

Canadian Respiratory Journal | April 3, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-5

10.1155/2018/6283935 | PMID 29849833 Get It

Introduction. The diagnostic standard forPneumocystis jiroveciipneumonia (PCP) is direct microscopic identification; however, in recent years, polymerase chain reaction (PCR) from bronchoalveolar lavage (BAL) samples to detectPneumocystisnucleic acids has proven to be more sensitive and specific. Sputum samples have been presumed inferior to bronchoscopic samples secondary to variability and adequacy of sample collection. We observed several cases of positive sputum PCP-PCR results with negative PCP-PCR BAL results. The aim of the current study was to further characterize the clinical setting and outcomes in patients with positive sputum PCP-PCR samples and negative BAL PCP-PCR samples.Methods. We identified all patients who underwentP. jirovecii-PCR testing at Mayo Clinic between 2011 and 2016. Patients with a positive sputum and negative BAL sample collected within a 14-day time frame were identified and underwent further chart review for demographics, immunocompromised state, and clinical outcome.Results. From 2011 to 2016, 4431 respiratory samples from 3021 unique patients were tested for the presence ofP. jiroveciiby PCR. Fifty-five samples (1.2% of all samples collected) belonging to 24 unique patients (0.79% of patients tested) were identified as having a positive and negative sample collected within 14 days. Of these 24 patients, 10 (46%) patients had a positive sputum or tracheal secretion sample with negative BAL or bronchial washings. Out of these 10 patients, 8 were immunocompromised and 9 underwent treatment for PCP with 6 patients improving.Conclusion. Our results suggest that discordantP. jirovecii-PCR testing results from sputum and bronchoscopic specimens are an infrequent occurrence. Patients with positiveP. jirovecii-PCR sputum/tracheal secretion samples and negative bronchoscopic samples appear to be clinically infected and respond to PCP treatment. SputumP. jirovecii-PCR testing may be a viable alternative to invasive testing.
Why Don’t Cancer Survivors Quit Smoking? An Evaluation of Readiness for Smoking Cessation in Cancer Survivors
Little, Melissa A. , Klesges, Robert C. , Bursac, Zoran , Ebbert, Jon O. , Halbert, Jennifer P. , Dunkle, Andrew N., Colvin, Lauren, Goedecke, Patricia J. , Weksler, Benny

Mayo Clinic

Journal of Cancer Prevention | April 3, 2018 | Volume: 23 | Issue: 1 | Pages: 44-50

10.15430/jcp.2018.23.1.44 | PMID 29629348 Get It

Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Link, Brian K. , Day, Bann‐Mo, Zhou, Xiaolei , Dawson, Keith, Cerhan, James R. , Flowers, Christopher R. , Friedberg, Jonathan W. , Cerhan, James R , Link, Brian K , Zelenetz, Andrew D.

Mayo Clinic

British Journal of Haematology | April 3, 2018 | Volume: 184 | Issue: 4 | Pages: 660-663

10.1111/bjh.15149 | PMID 29611177 Get It

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
Gadoth, Avi , Ζεκερίδου, Αναστασία , Klein, Christopher J. , Thoreson, Colton J., Majed, Masoud , Dubey, Divyanshu , McKeon, Andrew , Jenkins, Sarah M. , Lennon, Vanda A. , Pittock, Sean J. , Zekeridou, Anastasia, Pittock, S J , Klein, Christopher J , McKeon, Andrew , Dubey, Divyanshu , Flanagan, Eoin P.

Mayo Clinic

Annals of Clinical and Translational Neurology | April 2, 2018 | Volume: 5 | Issue: 5 | Pages: 646-650

10.1002/acn3.561 | PMID 29761127 Get It

AbstractTo determine whether CSF leucine‐rich glioma‐inactivated 1(LGI1)‐IgG titer, index or IgG subclass has prognostic significance, we tested serum and CSF specimens collected concomitantly from 39 seropositive patients. LGI1‐IgG index was elevated (>1) in 21 patients (54%), suggesting intrathecal synthesis. Patients with worse outcome at last follow‐up (modified Rankin Scale >2) had significantly higher index (median 6.57 vs. 0.5, P = 0.048) compared to those with better outcome. Higher CSF LGI1‐IgG4 subclass‐specific titer and index correlated with worse outcome (P < 0.005 for both). These data suggest that evidence of intrathecal LGI1‐IgG synthesis may correlate with neuronal injury and warrant consideration of aggressive immunotherapy.